Background/Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global epidemic. The disease has a strong genetic component, and a common missense variant (rs2642438) in the mitochondrial amidoxime-reducing component 1 (MARC1) gene confers protection against its onset and severity. However, there are contrasting results regarding the mechanisms that promote this protection.
Methods We downregulated MARC1 in primary human hepatocytes (PHHs) using short interfering RNA (siRNA). We measured neutral lipid content by Oil-Red O staining and fatty acid oxidation by radiolabeled tracers. We also performed RNA-sequencing and proteomic analysis using LC-MS. Additionally, we analyzed data from 239,075 participants from the UK Biobank.
Results Downregulation of MARC1 reduced neutral lipid content in PHHs homozygous for the wild type (p.A165, risk), but not for the mutant (p.T165, protective), allele. We found that this reduction was mediated by increased fatty acid utilization via β-oxidation. Consistent with these results, we found that the levels of 3-hydroxybutyrate, a by-product of β-oxidation, were higher in carriers of the rs2642438 minor allele among samples from the UK biobank, indicating higher β-oxidation in these individuals. Moreover, downregulation of the MARC1 p.A165 variant resulted in a more favorable phenotype by reducing ferroptosis and reactive oxygen species levels.
Conclusions MARC1 downregulation in carriers of the risk allele results in lower hepatocyte neutral lipids content due to higher β-oxidation, while upregulating beneficial pathways involved in cell survival.
Citations
Citations to this article as recorded by
Loss of Mtarc1 Protects Against Steatotic Liver Disease in Mice Xiaofei Yin, Caroline Bickerton, Bryan MacDonald, Alessandro Arduini, Yunlong Shi, Mary Haas, Amy Deik, Mark Chaffin, Erika Kovacs‐Bogdan, Julian Avila Pacheco, Maiwen Amegadjie, Bidur Bhandary, Shayan Sadre, Thomas Rathjen, Irinna Papangeli, Raymond T. C Liver International.2026;[Epub] CrossRef
MTARC1 Inactivation Remodels Lipid Droplets to Protect Against Metabolic Fatty Liver Disease Meng Tie, Liwei Hu, Yunzhi Yang, Shaoxuan Song, Qihan Zhu, Jun Li, Wenjing Wang, Peng Xu, Juan Yu, Mengyue Wu, Tianheng Zhao, Delong Yuan, Hongyu Bao, Xiuyun Wang, Irfan J. Lodhi, Yong Chen, Yali Chen, Anyuan He Liver International.2026;[Epub] CrossRef
Lactobacillus plantarum-fermented persimmon juice alleviates alcohol-induced hepatic ferroptosis by activating the Keap1/Nrf2 antioxidant axis Huijuan Kuang, Qingyuan Ye, Juan Tong, Hong Fu, Zhiqiang Shi, Bin Zhu, Guotai Yang Frontiers in Microbiology.2026;[Epub] CrossRef
The many pathways driving liver inflammation in MASH Herbert Tilg, Timon E. Adolph, Stefano Romeo, Rohit Loomba Cell Metabolism.2026; 38(6): 1054. CrossRef
Metabolic dysfunction-associated steatotic liver disease: On track to become the dominant etiology of hepatocellular carcinoma: Reply to correspondence on “Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta- Jian Xu, Wei Zhang, Guo Wu, Jingdong Li Clinical and Molecular Hepatology.2026; 32(2): e257. CrossRef
Opportunities and challenges in controlling metabolic dysfunction-associated steatotic liver disease: Editorial on “Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation” Jian Xu, Gang Shi, Tao Sheng, Jingdong Li Clinical and Molecular Hepatology.2026; 32(2): 919. CrossRef
MTARC1 p.A165 ablation reduces hepatocellular carcinoma aggressiveness in vitro and in vivo Lohitesh Kovooru, Jingjing Zhang, Francesco Giuseppe Monni, Tanmoy Dutta, Xiangdong Gongye, Bernice Asiedu, Patrizia Infelise, Emelie Barreby, Oveis Jamialahmadi, Margit Mahlapuu, Rosellina M. Mancina, Stefano Romeo Clinical and Molecular Hepatology.2026; 32(2): 829. CrossRef
Correspondence to editorial on “Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation” Ester Ciociola, Tanmoy Dutta, Rosellina M. Mancina, Stefano Romeo Clinical and Molecular Hepatology.2026; 32(2): e216. CrossRef
Genetic risk of steatotic liver disease: Pathogenesis, prognosis, and implications for treatment Julia Kozlitina, Stefano Romeo, Helen H. Hobbs Hepatology.2026;[Epub] CrossRef
Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology Carlos José Pirola, Silvia Sookoian Med.2026; 7(6): 101131. CrossRef
Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease Nicholas O. Davidson Circulation Research.2026;[Epub] CrossRef
Circadian Disruption Is Associated with Elevated Whole-Semen mtDNA Copy Number and Implicates CRY1 as a Candidate Regulator in Humans and Mice Mengchao He, Chuanyu Chen, Jing Gu, Yimeng Wang, Yingzhong Dai, Siwen Luo, Xiaolu Zhao, Baojian Wu, Jia Cao, Qing Chen International Journal of Molecular Sciences.2026; 27(15): 6569. CrossRef
Correspondence to editorial 2 on “Hepatocytic ankyrin repeat and SOCS box protein 3 deficiency alleviates metabolic dysfunction-associated steatotic liver disease by decreasing ubiquitin-mediated carnitine palmitoyl transferase 1A” Dongqin Yang, Yuli Lin, Chunhua Song, Ming Guan Clinical and Molecular Hepatology.2026; 32(3): e342. CrossRef
Mitochondrial DNA in systemic lupus erythematosus: pathogenic mechanisms, clinical biomarkers, and precision therapeutic strategies Fugang Huang, Ke Sun, Lijia Diao, Keda Lu, Yongsheng Fan, Guanqun Xie Frontiers in Immunology.2026;[Epub] CrossRef
Evolutionäre Aspekte der mit metabolischer Dysfunktion assoziierten steatotischen Lebererkrankung (MASLD) Andreas Geier, Stephan Schiffels, Marcin Krawczyk Die Gastroenterologie.2025; 20(2): 94. CrossRef
Identification of Novel Therapeutic Targets for MAFLD Based on Bioinformatics Analysis Combined with Mendelian Randomization Jialin Ren, Min Wu International Journal of Molecular Sciences.2025; 26(7): 3166. CrossRef
Lipid metabolism in liver transplantation: from challenge to chance Yuguan Zhang, Wang Rui, Xinhao Liu, Ya Ye, Sicheng Pu, Kezhen Zong, E Yang, Shanshan Li, Zuotian Huang, Zhongjun Wu Metabolism and Target Organ Damage.2025;[Epub] CrossRef
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism Rosellina M. Mancina, Luca Valenti, Stefano Romeo Nature Metabolism.2025; 7(11): 2199. CrossRef
Background/Aims Although the detrimental effects of several dietary components on the promotion of nonalcoholic fatty liver disease are well known, no studies have assessed the role of dietary vitamin B6. Moreover, studies on the associations between dietary components or body composition indices and liver steatosis assessed by transient elastography are rare. Our aim was to identify the nutritional factors and anthropometric parameters associated with liver steatosis.
Methods In this cross-sectional study, we enrolled 168 individuals (35% obese) who underwent a liver steatosis assessment by Controlled Attenuation Parameter measurement and nutritional assessment.
Results Tertiles of vitamin B6 intake were positively associated with hepatic steatosis (B=1.89, P=0.026, confidence interval [CI] 0.03-0.80) as well as with triglycerides, glucose, alanine aminotransferase (ALT), and body mass index . In obese individuals, after multivariable analysis, the Controlled Attenuation Parameter score was still associated with triglycerides, ALT, and total protein intake (B=0.56, P=0.01, CI 0.10-1.02). Participants in tertile I (low intake) had a lower Controlled Attenuation Parameter than those in tertile III (P=0.01).
Conclusions We found a positive association between hepatic steatosis or Controlled Attenuation Parameter score and vitamin B6/total protein intake, probably related to the high intake of meat. Vitamin B6 might have a pathogenic role related to the increase of hepatic steatosis.
Citations
Citations to this article as recorded by
From Fly to Human: Translational Relevance of Drosophila Models in the Study of Vitamin B6 and Cancer Relationship Fiammetta Vernì, Chiara Angioli, Angelo Ferriero, Beatrice Agostini International Journal of Molecular Sciences.2026; 27(6): 2877. CrossRef
Gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage Haiyuan Shen, Liangliang Zhou, Yuanru Yang, Hang Shu, Dongqing Wu, Simin Yang, Linxi Xie, Lei Yang, Shanfei Tian, Xinru Zhang, Rui Ma, Ling Jiang, Man Jiang, Hao Zhang, Yan Wang, Hejiao Zhang, Shan Gao, Long Xu, Hua Wang Hepatology Communications.2025;[Epub] CrossRef
Tocotrienol-rich fraction in medium-chain triglyceride carrier upregulates purine metabolism in non-alcoholic fatty liver disease (NAFLD) animal model Mohd Danial Mohd Efendy Goon, Sharaniza Ab-Rahim, Siti Hamimah Sheikh Abdul Kadir, Effendi Ibrahim, Musalmah Mazlan, Normala Abd Latip Egyptian Liver Journal.2025;[Epub] CrossRef
Exploring the role of gut microbiota in inflammatory bowel disease patients comorbid with non-alcoholic fatty liver disease Jiachen Hu, Chen Zhou, Lu Zhang, Yuzhu Chen, Jun Li, Junxia Li, Liping Duan Gut Pathogens.2025;[Epub] CrossRef
Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review Muhammad Y. Sheikh, Muhammad F. Younus, Annie Shergill, Muhammad N. Hasan International Journal of Molecular Sciences.2025; 26(19): 9625. CrossRef
A nutraceutical with Citrus bergamia and Cynara cardunculus improves endothelial function in adults with non-alcoholic fatty liver disease Samantha Maurotti, Roberta Pujia, Yvelise Ferro, Rosario Mare, Raffaella Russo, Adriana Coppola, Carmine Gazzaruso, Tiziana Montalcini, Arturo Pujia, Sara Paone, Vincenzo Mollace, Elisa Mazza Nutrition.2024; 118: 112294. CrossRef
Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients Jingwei Zhu, Zhe Wang, Xiaotong Sun, Dan Wang, Xinbo Xu, Liping Yang, Jiangdong Du, Zhimei Zhou, Yanhua Qi, Linfeng Ma Frontiers in Pharmacology.2024;[Epub] CrossRef
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective Yansong Fu, Zhipeng Wang, Hong Qin Metabolites.2024; 14(4): 218. CrossRef
Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease Magdalena Tyczyńska, Gabriela Hunek, Martyna Szczasny, Adam Brachet, Jacek Januszewski, Alicja Forma, Piero Portincasa, Jolanta Flieger, Jacek Baj International Journal of Molecular Sciences.2024; 25(9): 4916. CrossRef
Exploring the role of pyridoxal kinase: a key player in vitamin B6 metabolism Pallabi Banerjee, Risha Singh, Rajkumari Urmi, Manisha Singh, Anshuman Chandra, Nagendra Singh, Imteyaz Qamar Endocrinology & Metabolism International Journal.2024; 12(3): 68. CrossRef
Schisandrin A alleviates non-alcoholic fatty liver disease by improving liver metabolic disorders and suppressing the GSK3β signaling pathway Li Zong, Rui Xu, Yunxia Sun, Junjie Qiu, Huihui Tao, Chengyu Shentu, Hongxia Niu, Tengfei Xu, Yuan Zhou Food Bioscience.2024; 62: 105245. CrossRef
Association of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control study Swapna Chaturvedi, Divya Tripathi, Naval Kishore Vikram, Kumble S. Madhusudan, Ravindra Mohan Pandey, Neena Bhatia Human Nutrition & Metabolism.2023; 32: 200188. CrossRef
A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases Aliah R. Alshanwani, Hanan Hagar, Sameerah Shaheen, Ahlam M. Alhusaini, Maha M. Arafah, Laila M. Faddah, Fatima MB. Alharbi, Arun K. Sharma, Amel Fayed, Amira M. Badr European Journal of Pharmacology.2022; 923: 174910. CrossRef
Vitaminler ve Non Alkolik Yağlı Karaciğer Hastalığı Aziz KILINÇ, Yasemin AKDEVELİOĞLU Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi.2022; 6(2): 383. CrossRef
Hepatoprotective Effects of Ixeris chinensis on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice: An Integrated Gut Microbiota and Metabolomic Analysis Wenjie Jin, Sungbo Cho, Namujila Laxi, Terigele Bao, Lili Dai, Hongzhen Yu, Rigeer Qi, Junqing Zhang, Genna Ba, Minghai Fu Molecules.2022; 27(10): 3148. CrossRef
Association between the index of nutritional quality and lipid profile in adult women Saheb Abbas Torki, Effat Bahadori, Soheila Shekari, Soroor Fathi, Maryam Gholamalizadeh, Naeemeh Hasanpour Ardekanizadeh, Bahareh Aminnezhad, Mina Ahmadzadeh, Mahtab Sotoudeh, Fatemeh Shafie, Samira Rastgoo, Farhad Vahid, Saeid Doaei Endocrinology, Diabetes & Metabolism.2022;[Epub] CrossRef
Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease Yvelise Ferro, Samantha Maurotti, Elisa Mazza, Roberta Pujia, Angela Sciacqua, Vincenzo Musolino, Vincenzo Mollace, Arturo Pujia, Tiziana Montalcini Medicina.2022; 58(12): 1728. CrossRef
Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial Takashi Kobayashi, Takaomi Kessoku, Anna Ozaki, Michihiro Iwaki, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda, Satoru Saito, Atsushi Nakajima Journal of Clinical Biochemistry and Nutrition.2021; 68(2): 181. CrossRef
The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease Mikkel Parsberg Werge, Adrian McCann, Elisabeth Douglas Galsgaard, Dorte Holst, Anne Bugge, Nicolai J. Wewer Albrechtsen, Lise Lotte Gluud Journal of Clinical Medicine.2021; 10(5): 1081. CrossRef
The multifaceted role of vitamin B6 in cancer: Drosophila as a model system to investigate DNA damage Roberto Contestabile, Martino Luigi di Salvo, Victoria Bunik, Angela Tramonti, Fiammetta Vernì Open Biology.2020;[Epub] CrossRef
Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms Elisa Mascolo, Fiammetta Vernì International Journal of Molecular Sciences.2020; 21(10): 3669. CrossRef
Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years Yvelise Ferro, Tiziana Montalcini, Elisa Mazza, Daniela Foti, Elvira Angotti, Micaela Gliozzi, Saverio Nucera, Sara Paone, Ezio Bombardelli, Ilaria Aversa, Vincenzo Musolino, Vincenzo Mollace, Arturo Pujia Frontiers in Endocrinology.2020;[Epub] CrossRef
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases Rocco Spagnuolo, Tiziana Montalcini, Daniele De Bonis, Yvelise Ferro, Cristina Cosco, Elisa Mazza, Stefano Romeo, Patrizia Doldo, Arturo Pujia Nutrients.2019; 11(2): 303. CrossRef
Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group Farhad Vahid, Azita Hekmatdoost, Sousan Mirmajidi, Saeid Doaei, Diyako Rahmani, Zeinab Faghfoori The American Journal of the Medical Sciences.2019; 358(3): 212. CrossRef
Vitamin B6 deficiency in new born rats affects hepatic cardiolipin composition and oxidative phosphorylation Carmen Wolke, Sarah Gürtler, Daniela Peter, Jens Weingärtner, Grazyna Domanska, Uwe Lendeckel, Lorenz Schild Experimental Biology and Medicine.2019; 244(18): 1619. CrossRef
Diagnostic Performance of Serum Asialo-α1-acid Glycoprotein for Advanced Liver Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B or Nonalcoholic Fatty Liver Disease Seung Up Kim, Mi Young Jeon, Tae Seop Lim The Korean Journal of Gastroenterology.2019; 74(6): 341. CrossRef
Vitamin B6 improves blood parameters in rats fed a protein-deficient diet and subjected to moderate, long-term exercise Bolesław Kalicki, Aneta Lewicka, Krystyna Jęderka, Monika Leśniak, Justyna Marszałkowska-Jakubik, Sławomir Lewicki Central European Journal of Immunology.2019; 44(1): 23. CrossRef
Effect of the replacement of dietary vegetable oils with a low dose of extravirgin olive oil in the Mediterranean Diet on cognitive functions in the elderly Elisa Mazza, Antonietta Fava, Yvelise Ferro, Stefania Rotundo, Stefano Romeo, Domenico Bosco, Arturo Pujia, Tiziana Montalcini Journal of Translational Medicine.2018;[Epub] CrossRef
First
Prev
